Assisting in a HealthTech project with a focus on data assets
We advised a major pharmaceutical company in a HealthTech project with a focus on the possibility to gather
Search results
We hope you find what you are looking for. Please let us know if we can assist you.
27 results found.
reference
reference
Sale of Evondos Group
We advised Serendipity Partners and other sellers in the sale of Evondos Oy, the leading Nordic welfare technology
reference
Sale of Santen Pharmaceutical’s manufacturing facility
We advised Santen Pharmaceutical on certain aspects of the sale of its manufacturing facility in Tampere, Finland, to
insight
Reform of the Act on the Secondary Use of Social and Health Data
The Act on the Secondary Use of Social and Health Data (552/2019) is being reformed The Act on
insight
Implementation of the NIS2 Directive in Finland: New Cyber Security Requirements for Critical Sector Businesses and Entities
On 23 May 2024, Finland took a significant stride towards strengthening its cyber security legislation when the Government
insight
Examining Off-label Medicine Use in Paediatric Healthcare
Our life science experts Dr Juli Mansnérus, Charlotta Bonsdorff and Petro Vornanen seized the opportunity to contribute to
insight
D&I Transaction Powerhouse Deal Announcement
Continued High Activity Level in H1/2023 for D&I Transaction Powerhouse
insight
D&I Transaction Powerhouse Deal Announcement
High Level of Activity Continues in 2022 for D&I Transaction Powerhouse
insight
D&I Transaction Powerhouse
Deal Announcement
Continued High Level of Activity within a Wide Range of Industries
insight
Juli Mansnérus joins D&I Partnership
Innovation Powerhouse strengthened with IP and Life Sciences expert Juli Mansnérus.